XML 28 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Consolidated Statements of Earnings/(Loss) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]      
Revenue $ 226,827 $ 204,979 $ 181,326
Cost of products sold 219,413 198,105 174,842
Gross margin 7,414 6,874 6,484 Close
Operating expenses:       Close
Distribution, selling, general and administrative expenses 5,000 4,800 4,512 Close
Restructuring and employee severance 175 95 101 Close
Amortization and other acquisition-related costs 284 285 324 Close
Impairments and (gain)/loss on disposal of assets, net 634 1,246 2,060 Close
Litigation (recoveries)/charges, net 78 (304) 94 CloseClose
Total Operating Expenses 6171.0 6122.0 7091.0 0 0 Close
Operating earnings/(loss) 1,243 752 (607) Close
Other (income)/expense, net (9) 5 22 Close
Interest expense, net 51 84 147 Close
Loss on early extinguishment of debt 0 0 10 Close
Total Other Income Expenses 42.0 89.0 181.0 0 0 Close
(Gain)/Loss on sale of equity interest in naviHealth 0 0 2 CloseClose
Earnings/(loss) before income taxes 1,201 663 (784) Close
Provision for income taxes 348 332 153 Close
Net earnings/(loss) 853 331 (937) Close
Less: Net earnings attributable to noncontrolling interests (1) (1) (1)
Net earnings/(loss) attributable to Cardinal Health, Inc. $ 852 $ 330 $ (938)
Earnings/(loss) per common share attributable to Cardinal Health, Inc.      
Basic (in dollars per share) $ 3.48 $ 1.27 $ (3.37)
Diluted (in dollars per share) $ 3.45 $ 1.26 $ (3.37)
Weighted-average number of common shares outstanding:      
Basic (in shares) 245 261 279
Diluted (in shares) 247 262 279